Austin Harper, MD
Pain Medicine · Longview, TXNPI 1336559418
Payments from drug & device makers
Across 214 payments — averaging $40.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Abbott$2K
- Boston Scientific$2K
- Saluda Medical Americas, Inc.$529
- Nevro Corp.$411
- Wenzel Spine, Inc.$225
- plus $1K from 17 others
What the payments were for
- Travel & lodging$2,36027%
- Food & beverage$6,31773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 35 | $3,164 |
| Abbott | 85 | $1,673 |
| Boston Scientific | 32 | $1,547 |
| Saluda Medical Americas, Inc. | 11 | $529 |
| Nevro Corp. | 10 | $411 |
| Wenzel Spine, Inc. | 1 | $225 |
| Nalu Medical, Inc. | 6 | $191 |
| Vertos Medical, Inc. | 4 | $187 |
| AbbVie(2 entities) | 8 | $134 |
| Stimwave Technologies Incorporated | 1 | $93 |
| Biotronik NRO, Inc. | 3 | $74 |
| Biotissue Holdings Inc. | 1 | $71 |
| Tersera Therapeutics LLC | 3 | $63 |
| Stryker | 1 | $50 |
| SPR Therapeutics, Inc | 1 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $43 |
| Spinal Simplicity, LLC | 2 | $38 |
| Eisai Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Bioventus LLC | 1 | $25 |
| Si-bone, Inc. | 1 | $20 |
| Vertex | 1 | $18 |
| Globus Medical | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$2,033
- SUPERION$542
- Evoke SCS$285
- Promalok$225
- VANTA ADAPTIVESTIM$200
- INTELLIS$157
- Senza Spinal Cord Stimulation System$139
- Octrode SCS Leads$135
- PROCLAIM$128
- WAVEWRITER ALPHA$120
- GENERAL PAIN MANAGEMENT$109
- Omnia$101
How this compares
$8,677 in reported general payments places this provider in the 70th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 516 | $13,322 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 131 | $3,995 |
| Gabapentin | 84 | $1,064 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 37 | $1,004 |
| Pregabalin | 47 | $675 |
| Tramadol Hcl | 59 | $487 |
| Methylprednisolone | 47 | $325 |
| Tizanidine Hcl | 40 | $300 |
| Duloxetine Hcl | 12 | $259 |
| Nortriptyline Hcl | 33 | $239 |
| Meloxicam | 44 | $140 |
| Diclofenac Sodium | 16 | $123 |
| Amitriptyline Hcl | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Longview
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
- Candice BurnetteSugar Land$265K
- Ellen LinSan Antonio$251K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.